Year: 2025
Type: article
Abstract: Extract Intensive care unit (ICU)-acquired pneumonia, either ventilator-associated or hospital-acquired, represents a major clinical challenge that is associated with high mortality, prolonged hospitalisations, and increased cost [1, 2]. Prior research has focused on immunosuppression as the primary driver of infection susceptibility; however, clinical trials of immunostimulatory agents have been largely unsuccessful, suggesting that the pathogenesis of ICU-acquired pneumonia is more complex than previously appreciated [3–5].
Source: European Respiratory Journal
Language: English
Topic: Nosocomial Infections in ICU
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4409733219